QQQ   419.50 (-0.92%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   419.50 (-0.92%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   419.50 (-0.92%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   419.50 (-0.92%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
Free Trial
NASDAQ:CALA

Calithera Biosciences (CALA) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free CALA Stock Alerts
$0.03
-0.01 (-28.53%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.03
▼
$0.03
50-Day Range
$0.02
▼
$0.05
52-Week Range
$0.01
▼
$0.50
Volume
1,075 shs
Average Volume
857 shs
Market Capitalization
$121,993.50
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaSustainability
CALA stock logo

About Calithera Biosciences Stock (NASDAQ:CALA)

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

CALA Stock Price History

CALA Stock News Headlines

April 14, 2024 | americanbankingnews.com
Calithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews.com
February 24, 2024 | uk.investing.com
Arcus Biosciences Inc (RCUS)
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
August 12, 2023 | npr.org
Christina Cala
June 29, 2023 | seekingalpha.com
Calithera Biosciences cancels special meeting due to lack of quorum
June 1, 2023 | finance.yahoo.com
CALA - Calithera Biosciences, Inc.
May 20, 2023 | finanznachrichten.de
Calithera Biosciences, Inc.: Calithera Biosciences Announces Update on Complete Liquidation and Dissolution
May 19, 2023 | travel.usnews.com
Cala Mariolu
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
May 19, 2023 | seekingalpha.com
Calithera Biosciences plans special meeting to seek approval for liquidation and dissolution plan
May 19, 2023 | finance.yahoo.com
Calithera Biosciences Announces Update on Complete Liquidation and Dissolution
May 13, 2023 | travel.usnews.com
Cala Llombards
May 12, 2023 | investing.com
Calithera Biosciences Inc (CALA) Earnings Dates & Reports
January 11, 2023 | marketwatch.com
Calithera Biosciences Shares Plummet on Liquidation Plans >CALA
January 11, 2023 | marketwatch.com
Calithera Biosciences to Liquidate >CALA
January 10, 2023 | finance.yahoo.com
Biotech company Calithera plans its own death. Will others follow?
January 9, 2023 | finanznachrichten.de
Calithera Biosciences, Inc.: Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolution
January 9, 2023 | markets.businessinsider.com
Calithera Biosciences Board Of Directors Determine Dissolution Of Company
January 9, 2023 | finance.yahoo.com
Calithera Biosciences Stock Nosedives On Complete Liquidation, Dissolution
January 9, 2023 | finance.yahoo.com
Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolution
November 15, 2022 | finanznachrichten.de
Calithera Biosciences, Inc.: Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update
November 15, 2022 | seekingalpha.com
Calithera Biosciences, Inc. (CALA) Q3 2022 Earnings Call Transcript
November 15, 2022 | finance.yahoo.com
Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update
November 8, 2022 | finance.yahoo.com
Calithera Biosciences to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
October 3, 2022 | marketwatch.com
Calithera Biosciences Gets FDA Fast Track For Lung Cancer Drug
October 3, 2022 | nasdaq.com
Calithera Gets FDA Fast Track Designation For Sapanisertib For Squamous Lung Cancer Treatment
October 3, 2022 | finance.yahoo.com
Calithera's stock is up 14% after announcing Fast Track designation for lung-cancer drug candidate
See More Headlines
Receive CALA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2021
Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:CALA
CUSIP
N/A
CIK
1496671
Web
www.calithera.com
Phone
(650) 870-1000
Fax
N/A
Employees
8
Year Founded
2010

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$9.75 million
Price / Sales
0.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.40) per share
Price / Book
-0.06

Miscellaneous

Outstanding Shares
4,870,000
Free Float
4,550,000
Market Cap
$121,993.50
Optionable
Not Optionable
Beta
-0.17

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. Susan M. Molineaux Ph.D. (Age 70)
    Founder, CEO, President & Director
    Comp: $625.81k
  • Ms. Stephanie Wong (Age 50)
    CFO & Secretary
    Comp: $752.42k
  • Dr. Christopher J. Molineaux Ph.D. (Age 71)
    Senior Vice President of Development
    Comp: $405k
  • Mr. Frank Parlati Ph.D. (Age 55)
    Senior Vice President of Research

Key Competitors

View All Competitors

CALA Stock Analysis - Frequently Asked Questions

How have CALA shares performed in 2024?

Calithera Biosciences' stock was trading at $0.03 on January 1st, 2024. Since then, CALA stock has decreased by 16.5% and is now trading at $0.0251.
View the best growth stocks for 2024 here.

How were Calithera Biosciences' earnings last quarter?

Calithera Biosciences, Inc. (NASDAQ:CALA) posted its earnings results on Monday, November, 8th. The biotechnology company reported ($3.00) EPS for the quarter, topping analysts' consensus estimates of ($4.60) by $1.60. The biotechnology company earned $6.75 million during the quarter. During the same quarter last year, the company earned ($6.40) earnings per share.

When did Calithera Biosciences' stock split?

Calithera Biosciences's stock reverse split on the morning of Wednesday, June 15th 2022. The 1-20 reverse split was announced on Wednesday, June 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Calithera Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calithera Biosciences investors own include Puma Biotechnology (PBYI), Incyte (INCY), BioMarin Pharmaceutical (BMRN), (MDVN) (MDVN), Celadon Group (CGI), Dynavax Technologies (DVAX), Rigel Pharmaceuticals (RIGL), First Solar (FSLR), Plug Power (PLUG) and Sorrento Therapeutics (SRNE).

How do I buy shares of Calithera Biosciences?

Shares of CALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CALA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
My biggest AI fear
Paradigm Press
How Biden has already won 2024
Porter & Company
Options trading has suddenly become more reliable.
Eagle Publishing